Additional file 4 of Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data

Hanlon, Peter; Butterly, Elaine; Shah, Anoop S. V.; Hannigan, Laurie J.; Wild, Sarah H.; Guthrie, Bruce; Mair, Frances S.; Dias, Sofia; Welton, Nicky J.; McAllister, David A.

doi:10.6084/m9.figshare.21427306.v1

12916_2022_2594_MOESM4_ESM.pdf (746 kB)

Additional file 4 of Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data

journal contribution

posted on 2022-10-28, 07:44 authored by Peter Hanlon, Elaine Butterly, Anoop S. V. Shah, Laurie J. Hannigan, Sarah H. Wild, Bruce Guthrie, Frances S. Mair, Sofia Dias, Nicky J. Welton, David A. McAllister

Additional file 4. Statistical methods.

Funding

Wellcome Trust Medical Research Council

History

Usage metrics

Keywords

Randomised controlled trials Serious adverse events Multimorbidity Epidemiology Chronic disease

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 4 of Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data

Funding

Wellcome Trust Medical Research Council

History

Usage metrics

Categories

Keywords

Licence

Exports